NasdaqCM - NasdaqCM Real Time Price. Currency in USD
+0.0300 (+2.07%)
At close: 04:00PM EDT
1.4900 +0.01 (+0.68%)
After hours: 07:58PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close1.4500
Bid1.4800 x 27000
Ask1.4800 x 1200
Day's Range1.4600 - 1.5200
52 Week Range1.2900 - 3.9700
Avg. Volume3,055,053
Market Cap384.8M
Beta (5Y Monthly)3.74
PE Ratio (TTM)N/A
EPS (TTM)-1.0600
Earnings DateAug 10, 2023 - Aug 14, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SNDL

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • CNW Group

    SNDL Provides Update on the Nova Cannabis Strategic Partnership

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") is pleased to provide an update on its proposed Transaction (the "Transaction") with Nova Cannabis Inc. (TSX: NOVC) ("Nova") to create a well-capitalized cannabis retail platform in Canada, as contemplated by the implementation agreement entered into between the Company and Nova dated December 20, 2022, as amended on April 3, 2023 (the "Implementation Agreement"). The Company has amended the terms of the plan of arrangement (the "Original Plan o

  • Motley Fool

    Could These Be the Multi-State Marijuana Companies SNDL Is Planning to Partner With?

    Earlier this year, SNDL (NASDAQ: SNDL) dropped a big hint that it might end up owning a controlling stake in not one but two multi-state marijuana operators. It's a similar playbook to the one that its rivals Canopy Growth and Tilray Brands have been working out of: Expanding in the U.S. has been a cornerstone of their growth strategies. This month, SNDL identified which companies it has invested in, and that could give some hints as to the ones it might be looking to partner with.

  • Simply Wall St.

    SNDL First Quarter 2023 Earnings: EPS Misses Expectations

    SNDL ( NASDAQ:SNDL ) First Quarter 2023 Results Key Financial Results Revenue: CA$202.5m (up by CA$184.9m from 1Q...

  • PR Newswire

    SNDL Reports First Quarter 2023 Financial and Operational Results

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2023. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. The results for the first quarter of 2023 include the operating results of The Valens Company Inc. ("Valens") subsequent to the acquisition on January 17, 2023, and the results for the first quarter of 2022 include one day of Alcanna Inc.

  • Investopedia

    Top Cannabis Stocks for May 2023

    Cresco Labs, SNDL, and Green Thumb Industries top peers for best value, fastest growth, and best performance, respectively.

  • CNW Group

    SNDL to Announce First Quarter 2023 Financial Results on May 15, 2023

    SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that it will release its first quarter financial results for the period ended March 31, 2023, before market opens on Monday, May 15, 2023.

  • InvestorPlace

    7 F-Rated Stocks to Sell in May

    While investing in stocks is a terrific way to secure a comfortable retirement, your plans can go awry in plenty of ways. One of the worst is to find out (belatedly) that you have F-rated stocks that are holding you back. F-rated stocks get the worst grades from the Portfolio Grader. That’s the free tool that evaluates every stock based on earnings performance, momentum, analyst sentiment and other factors. The Portfolio Grader assigns an “A” through an “F” grade, and if you’ve got F-rated stock

  • Motley Fool

    2 Struggling Stocks I'd Avoid in May

    There are good reasons for that, as SNDL and Chegg face some uncertainty that should make most investors stay a safe distance away from both, at least for now. Canadian cannabis companies have faced severe headwinds over the past couple of years. SNDL has somewhat managed to avoid these issues by diversifying away from its cannabis operations and getting into the liquor retail business.

  • CNW Group

    Nova Cannabis Shareholders Vote in Favour of Strategic Partnership with SNDL

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") is pleased to announce that the shareholders of Nova Cannabis Inc. (TSX: NOVC) ("Nova"), excluding the Company and its associates and affiliates in accordance with Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (the "Disinterested Shareholders"), have approved a resolution (the "Transaction Resolution") in respect of the proposed transaction (the "Transaction") between SNDL and Nova to create a w

  • Motley Fool

    Has SNDL Become a Better Buy Than Tilray Brands and Canopy Growth?

    Don't look now, but SNDL (NASDAQ: SNDL) is becoming a better investment. While there's still no shortage of risk surrounding the business and the industry as a whole, SNDL is beginning to separate itself from the pack. Has it even become a better stock to buy than Tilray Brands (NASDAQ: TLRY) and Canopy Growth (NASDAQ: CGC)?

  • Motley Fool

    2 Stocks That Could Triple Your Investment by 2030

    Projecting a company's future growth is a great way to figure out which businesses can meaningfully expand over the long run and increase wealth and which ones are simply over-hyped. While one of them could be a risky investment, both have credible paths to making shareholders a richer. Novo Nordisk (NYSE: NVO) is a Danish pharma company that's been in the news lately, thanks to its drug semaglutide.

  • Motley Fool

    SNDL Just Made a Huge Announcement, But Is the Stock a Buy?

    The cannabis industry is no exception, and in that vein, SNDL (NASDAQ: SNDL) just dropped a bombshell announcement that might disrupt the North American marijuana industry, perhaps forever. Here's what's going on with this Canadian cannabis and alcohol company formerly known as Sundial Growers and why it's a critical concern for investors. In its fourth-quarter and full-year 2022 earnings report published April 24, SNDL casually mentioned that "the company expects that, on a structured and regulatory compliant basis, it may become a majority owner of one or more multi-state operators (MSOs) in the U.S. in 2023."

  • Motley Fool

    Is SNDL Stock a Buy Now?

    There were many reasons to be bullish on the company's latest earnings report, which came out on Monday.

  • PR Newswire

    SNDL Reports Full Year and Fourth Quarter 2022 Financial and Operational Results

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. Liquor retail includes operations for the period of March 31, 2022, to December 31, 2022, and cannabis retail includes the operations of Nova Cannabis Inc. ("Nova") retail stores for the period of March 31, 2022, to Dece

  • Motley Fool

    How Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023

    April 20th has a special significance for the cannabis industry. Three of those companies have especially attracted investors' attention in recent years -- Aurora Cannabis (NASDAQ: ACB), Curaleaf Holdings (OTC: CURLF), and SNDL (NASDAQ: SNDL) (formerly known as Sundial Growers). Aurora Cannabis is the worst of the group, with its share price plunging more than 80%.

  • Simply Wall St.

    Cautious Investors Not Rewarding SNDL Inc.'s (NASDAQ:SNDL) Performance Completely

    You may think that with a price-to-sales (or "P/S") ratio of 1.1x SNDL Inc. ( NASDAQ:SNDL ) is a stock worth checking...

  • CNW Group

    SNDL Granted MCTO Extension

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") announces that its principal regulator, the Alberta Securities Commission, has granted an extension to the existing management cease trade order granted on April 3, 2023 (the "MCTO") from April 14 to April 24, 2023.

  • InvestorPlace

    Just Say No to SNDL Stock

    Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation have found themselves stuck with a value trap. Despite the valuation discount, as the company has failed to achieve success with its business strategy (deploy its war

  • PR Newswire

    SNDL Announces Filing of Annual Report by April 24 and Provides Bi-Weekly MCTO Status Update

    SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") reports that the Company expects to file its audited consolidated financial statements for the year ended December 31, 2022, annual management's discussion and analysis for the same period, annual information form for the same period (which will be reported as an Annual Report on Form 20-F) and management certifications of annual filings (collectively, the "Filings"), on or before April 24, 2023, which will be within the applicable U.S. filing d

  • Motley Fool

    Proceed With Caution When Considering These 5 Ultra-Popular Stocks

    AMC Entertainment (NYSE: AMC), SNDL (NASDAQ: SNDL), Netflix (NASDAQ: NFLX), Editas Medicine (NASDAQ: EDIT), and Tilray Brands (NASDAQ: TLRY) are some of the more popular stocks among retail investors. With the exception of Editas Medicine, all of them appear on the Top 100 most popular list among users of the Robinhood Markets trading platform.

  • Motley Fool

    Is It Finally Time to Buy SNDL Stock?

    SNDL (NASDAQ: SNDL) is a business that's in the process of making a turnaround, and it might be successful. The Canadian company formerly known as Sundial Growers has come a long way from its origins and its time as a meme stock in 2021, and there's reason to believe that it could be a decent investment. Turnaround stocks tend to be risky, as do cannabis stocks, and SNDL is no exception because it's both.

  • Motley Fool

    Is SNDL Heading for Another Reverse Stock Split?

    The company is expecting its revenue to hit record levels this coming quarter, but can that be enough to turn things around?

  • PR Newswire

    SNDL Granted MCTO

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") announces that its principal regulator, the Alberta Securities Commission, has granted a management cease trade order (the "MCTO").

  • Motley Fool

    Down 80% in 1 Year, Is SNDL Stock Ready for a Bull Run?

    SNDL (NASDAQ: SNDL) shareholders have had a rough go of it, with the stock of the Canadian cannabis cultivator and banking company plummeting by 80% over the last 12 months. It has badly lagged behind the wider market, though it just barely ubnderperformed the wider cannabis industry as measured by the AdvisorShares Pure U.S. Cannabis ETF. In time, SNDL's stock might even go on a bull run, though it's not prudent to buy its shares in hopes of one happening tomorrow.

  • Investopedia

    Top Cannabis Stocks for April 2023

    Top-performing cannabis stocks include TerrAscend, OgraniGram Holdings, and Verano Holdings, which lead the industry in revenue growth even as inflation and declining demand hurt U.S. sales.